Edition:
India

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

80.42USD
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
$80.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
67,261
52-wk High
$107.32
52-wk Low
$60.09

Chart for

About

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product... (more)

Overall

Beta: 1.77
Market Cap(Mil.): $2,619.78
Shares Outstanding(Mil.): 27.24
Dividend: --
Yield (%): --

Financials

China Biologic rejects $3.9 billion bid from former CEO

China Biologic Products Holdings Inc rejected a $3.9 billion offer from a consortium led by its former chief executive on Friday and said an affiliate of CITIC Capital had also withdrawn a competing bid.

24 Aug 2018

UPDATE 3-China Biologic rejects $3.9 bln bid from former CEO

* Shares fall 14 pct (Adds former CEO-led consortium's comments)

24 Aug 2018

China Biologic rejects former CEO-led consortium's offer

Aug 24 China Biologic Products Holdings Inc said on Friday it had rejected an offer from a consortium led by its former chief executive and the company said an affiliate of CITIC Capital unit had withdrawn a competing offer.

24 Aug 2018

China Biologic gets $3.9 billion offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms, valuing the Beijing-based company at slightly above an earlier buyout proposal from a CITIC Capital unit.

21 Aug 2018

UPDATE 2-China Biologic gets $3.9 bln offer from former CEO-led consortium

* A Citic Capital unit offered $110 apiece for the company in June

21 Aug 2018

China Biologic gets $3.9 billion offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the company's former chief executive David Gao.

20 Aug 2018

CORRECTED-UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium

Aug 20 China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the company's former chief executive David Gao.

20 Aug 2018

CORRECTED-China Biologic gets $3.9 bln offer from former CEO-led consortium

Aug 20 China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium that included company's former chief executive, GL Capital Group, Bank of China Group Investment Limited and CDH Investments.

20 Aug 2018

Earnings vs. Estimates